LNTH · NASDAQ · STOCK
Lantheus Holdings (LNTH) Stock Analysis
$100.17
52W $50.16 – $111.86
63/100
$6.52B
23.8
-0.06
⚠
Buy rating, but near-term risk/reward is unfavorable
The long-term recommendation is based on the composite investment score. The near-term risk/reward is based on nearby support and resistance levels. These can differ when a strong company trades close to resistance with support further below.
Is LNTH Bullish or Bearish?
Bullish.
Innellis AI committee rates Lantheus Holdings (LNTH) Buy with a composite score of 63/100
, based on 6 analysts with 67% agreement.
Last updated October 10, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +11.87 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -8.13 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Risk Analyst sees a compelling case. Portfolio Manager remains cautious — sector concentration is already high (hhi 2796.97). This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- ROE of 23.3% shows genuine earnings power backing the valuation — Value
- 3 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Price-to-book of 4.0x prices in significant intangible value — Value
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 10, 2026
Overall Committee Score
63/100
Agreement
67%
Analysts
6
Conviction
Moderate
Sector Rank
Top 13%
of 192 Healthcare peers
Value Analyst
neutral
55
/ 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 23.3% shows genuine earnings power backing the valuation
− Price-to-book of 4.0x prices in significant intangible value
Growth Analyst
bullish
68
/ 100 · High confidence
Strong, accelerating growth with consistent execution
+ 3 consecutive earnings beats -- consistent execution
Technical Analyst
neutral
58
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
Risk Analyst
bullish
70
/ 100 · Low confidence
Risk profile is manageable -- leverage, volatility, and event exposure all look contained
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
bullish
62
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
Portfolio Manager
bearish
30
/ 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Investment Thesis Evolution
Committee score moved marginally from 63.1 to 63.1.
Comparing 2026-10-09 to 2026-10-10 (1 day apart).
Technical Analysis
RSI (14)
55.1
Neutral
MACD Histogram
0.084
Bullish Momentum
Trend Direction
Sideways
Weekly: Uptrend
Market Structure
Mixed
Support
$98.94
Resistance
$100.40
Bollinger %B
0.55
Inside Bands
Price vs Moving Averages
EMA 9
$100.04
Above
EMA 21
$100.15
Above
EMA 50
$100.45
Below
EMA 200
$91.64
Above
Fundamental Analysis
Valuation
37
Growth
83
Profitability
97
Financial Health
100
Cash Flow
70
Valuation
P/E Ratio
23.8×
P/B Ratio
4.97×
PEG Ratio
3.34
Dividend Yield
0.00%
52W High
$111.86
52W Low
$50.16
Quality & Growth
ROE
2143.1%
ROA
1048.6%
Gross Margin
6014.3%
Operating Margin
1942.7%
Revenue Growth YoY
—
Debt / Equity
0.48
AI Fundamental Assessment
P/E ratio of 23.8 (inexpensive relative to a 15-40x range); Price-to-book of 5.0x; PEG ratio of 3.3 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 21.4%; Return on assets of 10.5%; Net margin of 17.7%; Gross margin of 60.1%; Current ratio of 3.06 (healthy short-term liquidity); Debt-to-equity of 0.48; Free cash flow per share is positive (5.95); Most recent quarter beat estimates by 16.6%; 3 consecutive earnings beats; EPS growth accelerating (-12.6% -> +6.2% QoQ); Average YoY EPS growth of -1.3%; Analyst estimates rising over recent quarters
Get the Full LNTH Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →